Search

everythinglearnresearchcommunity

for

Search:↓

The anti-ageing treatment market is growing by exploiting fears of ageing with unproven promises, which could harm public trust and genuine science.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

Baricitinib may effectively treat nail changes in alopecia areata.

JAK inhibitors show promise in treating difficult skin diseases.

Jieduquyuziyin prescription helps treat SLE with atherosclerosis by improving cholesterol removal and reducing inflammation.

Prostaglandin E2 helps prevent hair loss from radiotherapy by protecting hair cells.

LPA 4 helps control blood and lymph vessel development in zebrafish.

Eclipta alba has potential health benefits, including anticancer and antibacterial properties.

Azelaic acid and finasteride can help preserve skin flaps after surgery by increasing BCL-2 protein and decreasing bax protein.

Cosmerna ARI effectively reduces hair loss and increases hair density in Europeans with androgenetic alopecia.

A-PRF+ improves bone healing and stability in oral surgery.

Reflectance confocal microscopy helped diagnose and manage a woman's hair loss without needing a biopsy.

Certain astrocytes can protect the brain and improve recovery after a stroke, and a hair loss drug might reduce cancer spread.

Rezpegaldesleukin shows promise for treating severe alopecia areata.

Ruxolitinib reduced inflammation and improved symptoms in APECED patients but may cause anemia and weight gain.

FR-1 reduces skin scarring and promotes healing without harmful effects.

Long-term data and a team approach are needed to manage chronic side effects from cancer treatments.

High-dose intravenous iron therapy doesn't interfere with treatment improvements in IBD patients with iron deficiency anemia.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

Eribulin-based chemotherapy is more effective and has fewer side effects for advanced triple-negative breast cancer.

Tofacitinib successfully treated hair loss in a Crohn's disease patient who previously used adalimumab.

Platelet-rich Plasma Gel may help treat en coup de sabre scleroderma, improving symptoms and skin quality with minimal side effects.

CARASIL can cause different symptoms even with the same genetic mutation.

Vismodegib can cause muscle spasms, taste changes, hair loss, fatigue, weight loss, and possibly new issues like skin cancer, dehydration, and swallowing problems, needing close monitoring.

Access to JAK inhibitor therapy for alopecia areata patients is difficult, especially for racial minorities.

AI in heart scans improves diagnosis and treatment but has risks like misdiagnosis and high costs.

Older patients sticking to their prostate medication saw lasting health benefits.

The combination of TACE and Donafenib is effective and tolerable for treating unresectable liver cancer.

Ritlecitinib improves hair regrowth in alopecia areata over 24 months.